By Associate Professor Orazio Vittorio

Preprints

Raninga P; Zeng B; Moi D; Saletta F; Venkat P; Mayoh C; D'Souza R; Day B; Shai-Hee T; Vittorio O; Mazzieri R; Dolcetti R; Khanna KK, 2024, CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers, http://dx.doi.org/10.21203/rs.3.rs-3957241/v1

Zhu J; Graziotto ME; Cottam V; Hawtrey T; Rouaen JRC; Ohno C; Heisler M; Vittorio O; Double KL; New EJ, 2023, A Near-Infrared Ratiometric Fluorescent Probe for Detecting Endogenous Cu2+ in the Brain, http://dx.doi.org/10.26434/chemrxiv-2023-mftg1

Rennie C; Sives C; Boyton I; Diaz D; Gorrie C; Vittorio O; Collins-Praino L; Care A, 2023, In vivofate of systemically administered encapsulin protein nanocages and implications for their use in targeted drug delivery, http://dx.doi.org/10.1101/2023.07.16.549228

Mayoh C; Gifford A; Terry R; Lau LMS; Wong M; Rao P; Shai-Hee T; Saletta F; Khuong-Quang D-A; Qin V; Mateos M; Meyran D; Miller K; Yuksel A; Mould EVA; Bowen-James R; Govender D; Senapati A; Zhukova N; Omer N; Dholaria H; Alvaro F; Tapp H; Diamond Y; Pozza LD; Moore A; Nicholls W; Gottardo N; McCowage G; Hansford J; Khaw S-L; Wood P; Catchpoole D; Cottrell C; Mardis E; Marshall G; Tyrrell V; Haber M; Ziegler D; Vittorio O; Trapani J; Cowley M; Neeson P; Ekert P, 2022, A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer, http://dx.doi.org/10.1101/2022.09.16.508179

Poursani EM; Mercatelli D; Raninga P; Bell JL; Saletta F; Kohane FV; Zheng Y; Rouaen J; Jue TR; Michniewicz FT; Kasiou E; Tsoli M; Cirillo G; Waters S; Shai-Hee T; Valli E; Brettle M; Whan R; Vahadat L; Ziegler D; Lock JG; Giorgi FM; Khanna KK; Vittorio O, 2022, Copper chelation inhibits TGF-βpathways and suppresses epithelial-mesenchymal transition in cancer, http://dx.doi.org/10.1101/2022.10.03.510707

Gargett T; Ebert L; Truong NTH; Kollis P; Sedivakova K; Yu W; Yeo ECF; Wittwer N; Gliddon B; Tea M; Ormsby R; Poonnoose S; Nowicki J; Vittorio O; Ziegler D; Pitson S; Brown M, 2022, GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma, http://dx.doi.org/10.1101/2022.05.01.490250

Ehteda A; Simon S; Franshaw L; Giorgi FM; Liu J; Hayden E; Joshi S; Ignatius Pang CN; Pandher R; Mayoh C; Tang Y; Rouaen J; Khan A; Ung C; Tolhurst O; Kankean A; Shen S; Gopalakrishnan A; Trebilcock P; Gurova K; Gudkov A; Norris M; Haber M; Vittorio O; Tsoli M; Ziegler DS, Dual Targeting of the Epigenome Via Facilitates Chromatin Transcription Complex (FACT) and Histone Deacetylase is a Potent Treatment Strategy for DIPG, http://dx.doi.org/10.2139/ssrn.3664176

Back to profile page